Covered recipient · General Payments record
MELISSA PATRICIA CO BUCHELI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2021–2024
$1,657.17
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $215.06 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $67.39 | 2 |
| Genentech USA, Inc. | $38.33 | 2 |
| Pyros Pharmaceuticals, Inc. | $28.02 | 1 |
| SK Life Science, Inc. | $22.71 | 1 |
| ACADIA Pharmaceuticals Inc | $17.38 | 1 |
| Kyowa Kirin, Inc. | $14.34 | 1 |
| ABBVIE INC. | $13.69 | 1 |
| Neurocrine BioSciences, Inc. | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.69 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103385437 | CMS |
| ACADIA Pharmaceuticals Inc | $17.38 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147964826 | CMS |
| Genentech USA, Inc. | $20.17 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133068286 | CMS |
| Genentech USA, Inc. | $18.16 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133068290 | CMS |
| Kyowa Kirin, Inc. | $14.34 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127037388 | CMS |
| Neurocrine Biosciences, Inc. | $13.20 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150879357 | CMS |
| Pyros Pharmaceuticals, Inc. | $28.02 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145043214 | CMS |
| SK Life Science, Inc. | $22.71 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154148090 | CMS |
| UCB, Inc. | $53.52 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143031226 | CMS |
| UCB, Inc. | $13.87 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143031228 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.